Rituximab in primary membranous nephropathy: beyond a B-cell-centered paradigm?

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)208-209
Number of pages2
JournalClinical and Experimental Nephrology
Volume22
Issue number1
DOIs
Publication statusPublished - Feb 2018

Keywords

  • Adult
  • Aged
  • B-Lymphocytes/drug effects
  • Female
  • Glomerulonephritis, Membranous/diagnosis
  • Humans
  • Immunologic Factors/therapeutic use
  • Male
  • Middle Aged
  • Nephrotic Syndrome/diagnosis
  • Recurrence
  • Remission Induction
  • Retrospective Studies
  • Rituximab/therapeutic use
  • Time Factors
  • Treatment Outcome

Cite this

@article{9993f568a6dd45e58616307c4ec2498d,
title = "Rituximab in primary membranous nephropathy: beyond a B-cell-centered paradigm?",
keywords = "Adult, Aged, B-Lymphocytes/drug effects, Female, Glomerulonephritis, Membranous/diagnosis, Humans, Immunologic Factors/therapeutic use, Male, Middle Aged, Nephrotic Syndrome/diagnosis, Recurrence, Remission Induction, Retrospective Studies, Rituximab/therapeutic use, Time Factors, Treatment Outcome",
author = "Pasquale Esposito and Fabrizio Grosjean and Filippo Mangione and Domenech, {Maria Valentina} and Teresa Rampino",
year = "2018",
month = "2",
doi = "10.1007/s10157-017-1437-2",
language = "English",
volume = "22",
pages = "208--209",
journal = "Clinical and Experimental Nephrology",
issn = "1342-1751",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Rituximab in primary membranous nephropathy

T2 - beyond a B-cell-centered paradigm?

AU - Esposito, Pasquale

AU - Grosjean, Fabrizio

AU - Mangione, Filippo

AU - Domenech, Maria Valentina

AU - Rampino, Teresa

PY - 2018/2

Y1 - 2018/2

KW - Adult

KW - Aged

KW - B-Lymphocytes/drug effects

KW - Female

KW - Glomerulonephritis, Membranous/diagnosis

KW - Humans

KW - Immunologic Factors/therapeutic use

KW - Male

KW - Middle Aged

KW - Nephrotic Syndrome/diagnosis

KW - Recurrence

KW - Remission Induction

KW - Retrospective Studies

KW - Rituximab/therapeutic use

KW - Time Factors

KW - Treatment Outcome

U2 - 10.1007/s10157-017-1437-2

DO - 10.1007/s10157-017-1437-2

M3 - Article

C2 - 28660444

VL - 22

SP - 208

EP - 209

JO - Clinical and Experimental Nephrology

JF - Clinical and Experimental Nephrology

SN - 1342-1751

IS - 1

ER -